Weekly News Amount
Total
${lastRankDetail.pages.length}
Financing ${lastRankDetail.financing_pages.length}
Product ${lastRankDetail.product_pages.length}
Negative ${lastRankDetail.sentiment_pages.length}
Abogen Biosciences is a developer of new nucleic acid drugs, which is dedicated to the research and development of new drugs based on nucleic acid (siRNA, mRNA, DNA). The target diseases include cancer and infectious diseases. At present, novel coronavirus mRNA vaccine (ARCoV) is being jointly developed by Abogen Biosciences, Academy of Military Medical Sciences and watson biological

Transactions

Funding 1 Fundings
Date Amount Round Relative News
Nov 2020 150 million CNY Series A AiBoShengWu received 150 million yuan in Series A financing and invested by Gaochun Venture Capital

Signals

Events ${currentEventsPage.count} Events
Events (${currentEventsPage.count}) Date
Nothing Happens :-(
${e.desp} ${e.date}
News ${ rankDetail.pages.length } News Articles ${currentTimeRange.start} ~ ${currentTimeRange.end}
Article (${rankDetail.pages.length}) Tag
${article.en_title} ${article.tag}
Industry Financing Info

Research

Intelligence 0 Research Briefs

Competition

Competitors 0 Competitors